You are here

In Silico Screening for Biothreat Countermeasures

Award Information
Agency: Department of Defense
Branch: Office for Chemical and Biological Defense
Contract: W911NF-05-C-0063
Agency Tracking Number: C051-106-0204
Amount: $69,353.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: CBD05-106
Solicitation Number: 2005.1
Timeline
Solicitation Year: 2005
Award Year: 2005
Award Start Date (Proposal Award Date): 2005-05-13
Award End Date (Contract End Date): 2005-11-15
Small Business Information
200 Innovation Blvd, Suite 261, State College, PA, 16803
DUNS: 172210572
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 Lance Westerhoff
 Chief Software Engineer
 (814) 235-6908
 lance@quantumbioinc.com
Business Contact
 Kevin Harter
Title: Chief Executive Officer
Phone: (717) 635-2107
Email: kevin@quantumbioinc.com
Research Institution
N/A
Abstract
The current state of the art of in silico drug discovery or computer aided drug discovery relies almost exclusively on molecular mechanics force fields, such as AMBER and CHARMM, and empirical potentials. It is well known that while these approaches are excellent for certain applications, they have thus far proven less then satisfactory for thorough understanding the interactions of enzyme-inhibitor systems when used in Ki or IC50 prediction and best pose selection. To address this issue, in the first part of the proposed research, we will utilize our linear scaling, quantum mechanics algorithm and collaborate with our industrial partners to further research, develop, and validate a quantum mechanics-based score function, called QMScore, capable of predicting Ki and binding modes to the levels of accuracy required by the in silico drug discovery world. In the second part of the project, we utilize a knowledge management and artificial intelligence platform to aide in the usability of this advanced methodology by researching the relationships between structure and QM convergence - the ultimate goal being the development of an intelligent and adaptive system for drug discovery.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government